Delivery Order HHSD200201461258I-HHSD2002014612580003
- This is a federal contract award to Westat, Inc., a prominent professional services firm, by the Centers for Disease Control and Prevention (CDC). The contract, valued at $117,308,763, is a Cost Plus Fixed Fee Definitive Contract with an ultimate completion date of December 31, 2012. The contract does not have a set-aside designation. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies, including the Department of...
- This is a Firm Fixed Price Delivery Order contract awarded by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, valued at $319,458.00, is for technical and management support services related to the Surveillance, Epidemiology, and End Results (SEER) Medicare Prostate Cancer Disparities program. The contract is not set aside for any specific business type. Westat has extensive experience...
- This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, titled "INTERDISCIPLINARY STUDIES OF OCCUPATIONAL AND ENVIRONMENTAL CANCER," has a ceiling value of $130,431,971.00 and a completion date of December 31, 2007. It is a cost-plus-fixed-fee contract, meaning the government reimburses the contractor for allowable costs incurred...
- This is a Firm Fixed Price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Westat, Inc., a prominent professional services firm. The contract, valued at $395,259.00, is for the provision of technical and management support services related to patterns of ovarian cancer care and survival in the Midwestern region of the United States. The contract is a task order under the CDC's Technical and Management Support for Health Promotion Activities Indefinite...
- This is a federal contract award to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services. The $10,071,871.00 cost-plus-fixed-fee contract is for biomedical (applied/exploratory) services and has a completion date of September 29, 2005. The contract is not set aside. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies,...
- This firm-fixed-price delivery order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract, valued at $255,154, is for quality control and quality improvement support related to the Surveillance, Epidemiology, and End Results (SEER) program, which is a key cancer research initiative supported by the National Cancer Institute. Westat, which has...
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for $624,407.00 to provide "Quality Control / Quality Improvement Support for the Surveillance, Epidemiology, and End Results (SEER) Program", which is a major cancer surveillance program operated by the NCI. The contract is a firm fixed-price purchase order with a period...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract, valued at $911,295.69, is for the CENTRAL DATA COLLECTION CENTER (CDCC) QUESTIONNAIRE AND BUCCAL CELL PROJECT, with a period of performance from September 19, 2016, to September 18, 2019. The contract does not have a set-aside...
- This is a Firm Fixed Price contract awarded to Westat, Inc. by the Centers for Disease Control and Prevention (CDC) for "HEALTH SYSTEM CHANGES TO ADDRESS RISK FACTORS IN CANCER". The contract is a call under the Achieving Public Health Impact Through Research (APHITR) Blanket Purchase Agreement (BPA), with a total ceiling value of $547,958.00 and a completion date of September 29, 2023. Westat, a for-profit professional services firm, has been providing a wide range of services to...
- This is a $65,127,025.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm. The contract is for clinical genetics branch support services, including services such as site study setup, protocol writing, and electronic patient-reported outcomes collection for cancer clinical trials. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies,...
- HHSD200201461258IIndefinite Delivery Contract
- HHSD200201461258I-HHSD2002014612580003Delivery Order
This is a federal contract award to Westat, Inc., a prominent professional services firm, by the Centers for Disease Control and Prevention (CDC) for the "NATIONAL PROGRAM OF CANCER REGISTRIES-DATA QUALITY EVALUATION" project. The $1,045,658.00 cost-plus-fixed-fee contract is a delivery order under the CDC's "Technical and Management Support for Health Promotion Activities" Indefinite Delivery Vehicle (IDV). The contract has no set-aside designation and will run through September 29, 2019. As part of this award, Westat will provide research, technical assistance, and program support services to the CDC's cancer registry program, leveraging the company's extensive experience in survey research, data collection and analysis, and program evaluation across various public health domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Other Administrative Action | ($13k) | 1/30/23 | |
| 3 | Exercise an Option | $354.7k | 7/10/18 | |
| 2 | Exercise an Option | $345.4k | 8/9/17 | |
| Not listed | Not listed | $345.6k | 6/14/16 | |
| 1 | Other Administrative Action | $0 | 6/14/16 |